The CLINUVEL brand, founded in 2006 (Australia), from 1 sister brand and 2214 competing brands. The CLINUVEL brand is owned by Clinuvel Pharmaceuticals, a company listed in Francfort. The International Securities Identification Number (ISIN) of Clinuvel Pharmaceuticals is AU000000CUV3. CLINUVEL belongs to the Biotechnology business sector.

CLINUVEL is a brand of Clinuvel Pharmaceuticals (UR9) Share price

International deposit : 2006 Business sector Biotechnology

Share price and profitability of the share Clinuvel Pharmaceuticals (CLINUVEL)

Buy Clinuvel Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 9.38

Portfolio valuation
Clinuvel Pharmaceuticals (CLINUVEL) over 5 years* EUR 4.65

Stock market history Clinuvel Pharmaceuticals (CLINUVEL)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Clinuvel Pharmaceuticals

See more brands of Clinuvel Pharmaceuticals

Rival brands
CLINUVEL

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS